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Background: Diabetes and its related microvascular complications like Diabetic retinopathy are showing an
alarming rise in developing countries like Zanzibar. Objective of the present study is to evaluate the impact of
integrating eye screening for all subjects attending the diabetes clinic at Mnazi Mmoja Hospital in Zanzibar and to
estimate the prevalence of visual impairment and diabetic retinopathy among the subjects.
Methods: This is a cross sectional study involving 356 randomly selected patients who had attended the diabetes
clinic between July and August 2012. All subjects underwent comprehensive eye examination including fundus
evaluation after dilatation by a cataract surgeon and an ophthalmologist, independently. Data was collected using
the designated questionnaire and analysed using the SPSS software. Blindness and visual impairment was defined
as presenting VA <3/60 and <6/18 to 6/60 in the better eye respectively and DR was graded using the International
classification of Diabetic Retinopathy severity grading scale.
Results: A total of 356/967 subjects were recruited in a duration of 2 months; 176 (49.4%) were male and the mean
age was 52.21 (SD 15.3). Targeted eye screening of diabetics showed that 231/356 (65%) of the subjects had eye
problems, including potentially blinding conditions that required immediate intervention in contrast to the existing
self reported referral where only 10% of an average of 200 diabetics underwent eye checkup in a year. The
prevalence of visual impairment was 20.2%; 95% CI: 16.4-24.7 and blindness in 9.3%; 95% CI: 6.7 -12.7. The prevalence
of DR was 28.3% and sight-threatening DR was reported in 9%. Among the DR cases, 30% had sight threatening DR
including 28% macular edema, 2% severe NPDR and PDR. Multivariate analysis showed a higher risk for any DR in older
subjects >50 years (OR: 2.19; 95% CI: 1.14 – 4.25) and in females (OR: 1.92; 95% CI: 1.07 – 3.44).
Conclusion: Opportunistic DR screening model achieved higher yield of identification of visual impairment and DR
compared to the yield of 10% of existing self reported Diabetic eye screening model at Zanzibar. Integration of eye
screening at diabetes clinics helps in early identification and provision of appropriate treatment for reducing blindness
due to diabetes.
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Diabetes is a major public health problem in both the
developed and the developing countries, particularly
type 2 diabetes, which is rising in epidemic proportions
[1]. Diabetic retinopathy is the fifth leading cause of glo-
bal blindness and an important cause of preventable
blindness if detected at an early stage [2]. Currently,
Africa is estimated to have more than 7 million people
with Diabetes and these figures are expected to be nearly
12.2 million by 2030 [3,4]. More than 482,000 East
Africans are now diagnosed to have type 2 diabetes [5].
Zanzibar is a part of the United Republic of Tanzania.
It has 1.2 million inhabitants according to the 2002
Country census survey [6]. Diabetes, and its related
complications like diabetic retinopathy are increasing
rapidly in Zanzibar and other African countries [7] due
to inadequate knowledge about the disease and its asso-
ciate complications among the communities and health
workers. Moreover, there have been substantial changes
in lifestyles and an increase in urbanization and in re-
duction of physical activities [8].
Unfortunately, due to the asymptomatic nature of dia-
betic retinopathy in the early stages, many patients present
late, when the damage is already rendered irreversible. In
the African region, a few hospital based DR prevalence
studies suggested prevalence estimates, ranging from 7%
to 63% [9,10]. It is estimated that more than 50% of DR
cases are undiagnosed in the community.
There is no previously published data on DR screening
models in Zanzibar. This calls for urgent initiatives to
promote education about diabetes and its related com-
plications, advocate for diabetes screening campaigns
and develop an effective DR screening model suitable
for Zanzibar.
WHO recommends dilated regular eye examination
for all persons with diabetes to identify eye problems at
an early stage and intervene to avoid blindness. An im-
portant feature of an effective DR screening model is to
have DR screening for the people with Diabetes at their
first contact that is a physician (i.e. Opportunistic DR
screening). The current referral pattern to the eye clinic
at Zanzibar is based on the self-reported eye complaints
by the diabetics. Currently, there are no facilities for
diagnosis or medical and surgical management of DR at
the eye unit in Zanzibar.
The present study is meant to find the efficacy of an
opportunistic DR screening model in terms of the yield
of DR, sight threatening DR and other causes of visual
impairment among people with Diabetes attending a
Government Diabetes clinic in Zanzibar.
Methods
This was a hospital-based cross sectional study involving
356 randomly selected patients who had attended aMnazi Mmoja Hospital diabetes clinic from July to Au-
gust 2012. Mnazi Mmoja Referral Hospital is the only
tertiary hospital in the country with facilities of various
departments that treat different cases.
The subjects were randomly recruited at the exclusive
diabetic outpatient’s clinic at the Mnazi Mmoja Referral
Hospital. The investigator approached all the patients at-
tending the diabetic clinic during the study period daily
and explained about the study. All those consented to
participate in the study was further interviewed before
the eye examination. All those diabetic patients who
were not interested to participate and who was seriously
ill and had difficulty to move to the eye clinic for exam-
ination was excluded from participation.
Informed consent was obtained from all participants
prior to recruitment in the study. Ethical approval
was obtained from Zanzibar Medical Research Ethical
Committee.
The study participants were interviewed and the infor-
mation was recorded using a designated questionnaire
by the investigator. Systemic parameters were measured
by trained nurses at the Diabetes clinic included blood
sugar (mmol/l) by digital Glucoplus machine, blood
pressure by digital BP machine (mmHg), weight (in
Kgs), height (in meters) and waist circumference (in me-
ters). Fasting blood sugar was classified as within normal
limits ≤ 6 mmol/l) and high as > 6 mmol/l and blood
pressure was classified as presence of hypertension ≥
140/90 mm of Hg and absence of hypertension when
blood pressure is within normal limits (120/80 – 110/
75 mmHg). BMI was considered as within Normal
(18.50- 24.99), overweight (25–30) and Obese if the
value was more than 30.
Ophthalmic Clinical Officers (Ophthalmic assistants)
were responsible for testing visual acuity with Snellen vi-
sion chart at a distance of 6 metres. Presenting visual
acuity of 6/18- 6/6 was considered as a normal vision,
presenting vision of <6/18 in the better eye was defined
as visual impairment, and presenting vision of <3/60 in
the better eye as blindness. Anterior segment examin-
ation by slit lamp and Intra ocular pressure using digital
tonopaf machine was done for all the subjects, prior to
pupillary dilatation by the cataract surgeons (cataract
surgeon is a non-ophthalmologist mid-level eye care
professional who is trained in general ophthalmology
and takes a course in cataract surgery for 1 year at a rec-
ognized institution and he/she only performs simple
cataract surgeries). Pupils were dilated using 1% tropica-
mide eye drops. Fundoscopy examination was performed
independently by a cataract surgeon and an ophthal-
mologist using indirect ophthalmoscope and 20Ds lens
after full dilatation of the subject’s pupil. Over 80%
agreement was achieved between the two ophthalmic
clinical officers for visual acuity assessment, the two
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the start of main study. There was perfect agreement
between the cataract surgeon and the ophthalmologist
in categorizing patients with different types of diabetic
retinopathy (DR), Kappa = 0.993 (95% Confidence Interval
(CI): 0.980, 1.000).
Diabetic retinopathy (DR) was graded using the Inter-
national classification of Diabetic Retinopathy severity
grading scale [11] as No DR, Mild non proliferative DR
(mild NPDR), Moderate non proliferative DR (moderate
NPDR), Severe Non Proliferative DR (NPDR), Prolifera-
tive diabetic retinopathy (PDR) and Macular edema.
Sight threatening retinopathy was defined as any eye
having Severe NPDR, PDR and Macular edema.
All data collected was entered into a database and
analysed using the SPSS software 16.0 version. The
prevalence of visual impairment, eye diseases and dia-
betic retinopathy was calculated for different age
groups and gender. Univariate and multivariate regres-
sion analysis was used to determine the factors associ-
ated with DR and a p value <0.05 was considered
statistically significant. The data obtained during the
study was correlated with the past statistics maintained
at the hospital to report the effectiveness of this
methodology.
Results
A total of 356 subjects were recruited out of 967 pa-
tients who had attended the diabetes clinic during the
study period. The mean age of subjects was 54.27 years
(SD 12.7) and 50.6% (180) were women and 5% were
children. The socio economic characteristics of the study
subjects gender wise is presented in Table 1.
A majority of the subjects had Type 2 diabetes — 315
(89%) and the mean duration of diabetes was 6.86 years
(SD 5.59 years). The prevalence of known hypertension
among the subjects was 199 (56%); and it was more in
females as compared to males (32% vs 24%; p 0.004).
The mean duration of hypertension was 7.14 years (SD
6.57 years). A total of 155 (43%) subjects had a BMI
above 25, and obesity (BMI >30) was significantly higher
among females as compared to males (26.1% vs 7.4%;
p <0.001).
Figure 1 shows the comparison of patients with dia-
betes attending diabetic and eye clinic in the same ter-
tiary hospital. We compared the number of persons
attending the diabetes clinic and the number of diabetic
cases with eye problems that attended the eye clinic in
the last five years.
During this study period of two months, 231/356
(65%) of the subjects with Diabetes having eye problems
that requires further treatment were identified. In con-
trast, it was observed that an average of only 10% (Range
142–200 subjects) of individuals with diabetes who hadreported having eye problems attended the eye clinic
every year.
A total of 206/356 (57.9%) subjects reported having
experienced eye problems at the time of the interview,
of whom 58% were female. Of these, 61 (30%) had never
accessed eye care services earlier, despite having eye
problems, 71 (34%) had accessed only once and 74
(36%) had accessed more than once earlier.
Table 2 shows the prevalence of visual Impairment
and blindness among the study subjects. The prevalence
of Visual Impairment was seen in 20.2%; 95% CI: 16.4 -24.7
and blindness was seen in 9.3%; 95% CI: 6.7 -12.7 of
subjects. About 5% of the subjects vision improved with
pin hole. Prevalence of eye problems was recorded in
59% of the subjects. Cataract was diagnosed in 178 eyes
and high IOP > 21 mmHg in 59 eyes.
The prevalence of DR was found in 101 (28.3%) sub-
jects and sight-threatening DR was reported in 33
(9%) subjects with Diabetes. Among the DR cases, 56%
had mild DR, 12% had moderate, 2% had severe DR
or proliferative diabetic retinopathy (PDR) and 28%
had macular oedema. The multiple logistic regression
analysis (Table 3) shows that persons aged >50 years
had a higher risk of developing any DR, as compared
to <50 years age (OR: 2.19; 95% CI: 1.14 – 4.25) and
the risk was statistically significant. Females were
more at risk as compared to males and increase in
duration of diabetes was significantly associated with
any DR and sight-threatening DR. Persons who pre-
sented with visual impairment had twice the risk for
any DR (OR: 2.71; 95% CI: 1.56 – 4.7) and thrice for
sight-threatening DR (OR: 3.75; 95% CI: 1.61 – 8.72).
Discussion
Currently, the model of self reported Diabetes eye
screening at Zanzibar yields only less than 10% eye
patients of the persons attending the diabetic clinic,
who access the eye clinic located within the same hos-
pital premises. The reason for the low uptake of eye
care services by the diabetic population may be due
to lack of awareness among the diabetic community
and insufficient counseling on the importance of eye
screening, as it is not a mandatory part of the treat-
ment protocol.
Our study of opportunistic eye screening at the Dia-
betes clinic showed a significant yield of people with dia-
betes (65%) having eye problems as compared to only
10% of current self reported eye screening for people
with Diabetes at Zanzibar. This study found that the
prevalence of DR was 28.3% (101/356) and sight-
threatening diabetic retinopathy was 9% (32/356) among
the study subjects. Our findings match with previous
reports from Africa on DR prevalence ranging from
16 – 55% [12].
Table 1 Socio-demographic characteristics of study subjects by gender
Socio-demographic status Female (%) Male (%) Total (%) P value
Age group
6 –18 yrs 11 (3.1) 7 (2.0) 18 (5.1)
0.1819 – 49 yrs 53 (14.9) 58 (16.3) 111 (31.2)
50 and above 112 (31.5) 115 (32.3 227 (63.6)
Educational level
Never been to school 81 (23) 33 (9.3) 114 (32.3)
<0.001Primary & secondary school 98 (27.5) 131 (36.8) 229 (64.4)
Graduate and above 2 (0.6) 11 (3.2) 13 (3.8)
Occupation
Govt .employees & Entrepreneurships 41 (11.5) 119 (33.5) 160 (45.0)
<0.001
Students 6 (1.7) 13 (3.7) 19 (5.4)
Retired from government 5 (1.7) 32 (9) 37 (10.4)
Housewife/non-workers 128 (36.1) 12 (3.4) 140 (39.4)
Location
Urban 78 (21.9) 80 (22.5) 158 (44.4)
0.43Rural 92 (25.8) 81 (22.8) 173 (48.6)
Semi-urban 10 (2.8) 15 (4.2) 25 (7.0)
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geon and the ophthalmologist, as the ophthalmologist
was the only Gold standard, and it indicates that if there
is continuous training and upgrading of these cadres, go-
ing forward, cataract surgeons can help detect DR in the
early stages, both at the tertiary diabetes clinic and at
the primary health care centre level.
Introduction of mandatory eye screening for all per-
sons attending the diabetic clinic can greatly helpFigure 1 Comparative statistics of diabetic persons attending
diabetes and eye clinic in the past 5 years with the
study period.identify potentially blinding conditions, including DR
[13]. However, identification alone will not serve the
purpose, unless appropriate treatment facilities and in-
frastructure are created at the eye clinic. The number of
patients, who had severe non-proliferative retinopathy
and proliferative retinopathy, requiring laser treatment,
was as high as 9% in the study group. This suggests that
the hospital management should explore the possibilities
of establishing a medical retina unit to provide laser
treatment for those in need at this level.
Our study reports the prevalence of Visual impair-
ment, DR among the patients attending the diabetes
clinic at the tertiary centre. Our study found high preva-
lence of type 2 Diabetes in Zanzibar, 315 (89%) among
the subjects, indicating problems in lifestyle practices
and this is confirmed by the high incidence of over-
weight (27%) and obesity (17%) among the subjects. Our
reports are higher compared to previous reports from
the region, regarding the prevalence of obesity among
the diabetes. It was 0.2% among males in Tanzania [14]
and 21% among females in urban Cameroon [15]. This
is likely to increase in the future with increasing
urbanization and as lifestyles shift towards reduced exer-
cise levels, increased stress and unhealthy foods. Inter-
estingly, a study by Martorrel et al. noted a similar
situation with South African woman, where it is cultur-
ally believed that obesity reflects health and wealth [16].
More than half of the subjects (56%) reported having a
history of high blood pressure (>210/120 to 140/
90 mmHg) and this indicates that there is an added risk
of developing other cardiovascular diseases and a risk of





Normal (6/6 – 6/18) 251 (70.5) 65.6 – 75.0
Moderate VI (<6/18 – 6/60) 72 (20.2) 16.4 – 24.7
Blind (<3/60 to no perception of light) 33 (9.3) 6.7 – 12.7
Total 356 (100)
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to be managed as early as possible. At the time of recruit-
ment for the study, the fasting blood sugar was high in
300 (84%) subjects and the presenting blood pressure was
raised in 207 (56%) subjects. This high prevalence of sub-
optimal glycemic and blood pressure control is a cause for
concern [19,20] and reveals a lack of diabetes care at the
primary care level; this report is almost similar to the pre-
vious report from South Africa [21].
Cataract was diagnosed in 178 eyes and 59 eyes had in-
creased IOP of greater than 21 mmHg. There is published
evidence that the risk of cataract increases with anTable 3 Factors associated with diabetic retinopathy (DR) usi
Variables Total n = 352 (%)
Age (years)
< 50 years 128 (36)









<5 years 176 (50)
6 -10 years 109 (31)
11 – 15 years 38 (11)
16 and above 29 (8)




Normal range 54 (15)
High 298 (85)
Visual acuity*
Normal range 250 (70)
Visually impaired 102 (30)
*4 persons had dense cataract and there was no view, hence they are not includedincreased duration of diabetes and severity of hypergly-
cemia [22]. There is also a strong positive association be-
tween diabetes with primary open angle glaucoma, the
most common form of glaucoma or elevated intraocular
pressure in the absence of optic neuropathy [23,24].
Persons above the age of 50 years were twice at risk of
developing any DR than younger persons, with an odds
ratio of 2.19 with 95% Cl (1.14 -4.25). If this could have
been seen and diagnosed earlier, most of these cases
would have been treated. However, utilization of eye care
services was poor with 61 (30%) study subjects never
accessing eye care services, despite having eye problems.
The barriers to accessing eye services included inad-
equate health education amongst diabetic patients and
health care personnel. There is no diabetic screening
protocol for these patients, which is vital for the early
detection of DR. Instead, the eye clinic at Mnazi Mmoja
Hospital depends on self-reported eye complaints, which
often means that patients present late. This indicates
that currently the majority of diabetic patients will pro-
gress to visual impairment, if screening and refractive
services are not implemented.ng multiple logistic regression
Adjusted odds ratio (95% CI) P value
1
0.020
2.19 (1.14 – 4.25)
1
0.028
1.92 (1.07 – 3.44)
1
0.17
1.53 (0.84 – 2.79)
1.61 (0.78 – 3.32) 0.19
1
0.17
1.53 (0.83 – 2.82)
4.06 (1.76 – 9.36) 0.001
2.67 (1.08 – 6.58) 0.03
1
0.33
1.35 (0.74 – 2.44)
1
0.88
1.06 (0.52 – 2.14)
1
<0.001
2.71 (1.56 – 4.7)
for this calculation.
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eye problems and DR among persons with diabetes in
Zanzibar. Being the only tertiary and referral centre at
the country, the possibility of attracting patients from all
over the country was high, which was evident from the
study subjects. The sample drawn for the study repre-
sented all the geographic zones in the country. Any stra-
tegic change here to improve patient care would benefit a
large section of the community across the country. More-
over, this hospital is managed by the Ministry of Health,
Zanzibar, with very good linkages both upwards with other
tertiary centres at the Mainland, Tanzania, and downwards
with all the Primary Health Care Centres, spread over the
region. The primary health care units and centres can play
a more active role in future by adopting an integrated
approach for both diabetes and blindness prevention,
through proactive screening, identification, referral and
health promotion.
The main limitation of the study was that it was a hos-
pital based study, and not a representative sample for
the whole country. Although the study would help hos-
pital policy makers to standardize the eye screening
protocol for persons with diabetes attending the hospital,
it will not allow us to extrapolate the information to the
rest of the population.
Another limitation of this study was the DR grading
done by the ophthalmologist. The method of grading
was subjective, using indirect ophthalmoscope after dila-
tion. Although the screening sensitivity of this method
by an ophthalmologist showed a sensitivity of 74% in de-
tecting DR in earlier reports [25], an objective evaluation
using fundus photography would have been ideal. How-
ever, with existing resource constraints in the country,
the ophthalmologist’s grading is the only possible gold
standard for DR grading. Another important limitation
of the study was slitlamp biomicroscopy with 78D was
not done for DR grading. This would have resulted in
possible underestimation of prevalence of DR. The find-
ings from this study would help the management to ex-
pand its infrastructure for the treatment of diabetic eye
diseases.
Conclusion
We conclude that the prevalence of diabetic retinopathy
and visual impairment due to other treatable causes was
found to be high among the study subjects. Based on the
findings, we recommend that eye screening for diabetic
persons attending the MMH diabetes clinic be included
as part of the regular screening protocol to detect DR
and other treatable eye problems at an early stage, thus
facilitating blindness prevention. The current findings
are based on individuals who accessed the MMH dia-
betes clinic for their regular treatment. However, the
number of persons with diabetes and eye problems willbe much more in the community, which indicates a need
to conduct further countrywide research to establish na-
tional statistics.
Competing interests
The authors declare that they have no competing financial or nonfinancial
interests.
Authors’ contributions
FO carried out the study, analysed the results and drafted the manuscript. SS
participated in concept, design, writing, editing and review of the
manuscript, RPK participated in concept, design, writing, editing and review
of the manuscript, GN participated in the study and GK participated in the
design of the study. All authors read and approved the final manuscript.
Author’ information
Fatma Juma Omar (FO): Master of Community Eye Health Program Student.
Sethu Sheeladevi (SS): Visiting Adjunct Lecture, School of Optometry and
Vision Science, UNSW and Associate Public Health Specialist, L V Prasad Eye
Institute, Hyderabad, India.
Dr. Padmaja Kumari Rani (RPK): Visiting Adjunct Lecture, School of Optometry
& Vision Science, UNSW and Retina Consultant, L V Prasad Eye Institute,
Hyderabad, India.
Dr. Geng Ning (GN): Consultant Ophthalmologist (Mnazi Mmoja Referral Hospital).
Dr. George Kabona (GK): Ophthalmologist (Iringa Referral Hospital).
Acknowledgements
The Ministry of Health, the Revolutionary Government of Zanzibar for the
financial support, Mnazi Mmoja Hospital management, staff at Diabetes and
Eye clinic and all the study subjects.
Author details
1Gullapalli Pratibha Rao International Center for Advancement of Rural Eye
Care, L V Prasad Eye Institute, Hyderabad, India. 2Mnazi Mmoja Referral
Hospital, Zanzibar, Tanzania. 3School of Optometry & Vision Science,
University of New South Wales, New South Wales, Australia. 4Srimati Kannuri
Santhamma Centre for VitreoRetinal Diseases, Kallam Anji Reddy Campus,L V
Prasad Eye Institute, L V Prasad Marg, Hyderabad, India. 5Iringa Regional
Referral Hospital, Iringa, Tanzania.
Received: 27 January 2014 Accepted: 20 June 2014
Published: 24 June 2014
References
1. Cheung N, Mitchell P, Wong TY: Diabetic retinopathy. Lancet 2010, 376
(9735):124–136.
2. Ding J, Wong TY: Current epidemiology of diabetic retinopathy and
diabetic macular edema. Curr Diab Rep 2012, 12(4):346–354.
3. World health organization: State of the world's sight: VISION 2020: the Right
to Sight: 1999-2005. (http://apps.who.int/iris/handle/10665/43300).
4. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025:
prevalence, numerical estimates, and projections. Diabetes Care 1998,
21(9):1414–1431.
5. World Health Organization: Core health indicators: the latest data from
multiple WHO sources. United Republic of Tanzania. Geneva: WHO; 2006.
http://www.who.int/gho/countries/tza/en/.
6. Zanzibar RG: Zanzibar Demographic Census 2002 Cdc. http://www.geohive.
com/cntry/tanzania.aspx.
7. Gabriel N: The Global pandemic of diabetes-an update. Afr J Diabetes Med
2009, 17(11):4–8.
8. Levitt NS, Bradshaw D, Zwarenstein MF, Bawa AA, Maphumolo S: Audit of
public sector primary diabetes care in Cape Town, South Africa: high
prevalence of complications, uncontrolled hyperglycaemia, and
hypertension. Diabet Med 1997, 14(12):1073–1077.
9. Levitt NS, Steyn K, Lambert EV, Reagon G, Lombard CJ, Fourie JM, Rossouw K,
Hoffman M: Modifiable risk factors for Type 2 diabetes mellitus in a peri-
urban community in South Africa. Diabet Med 1999, 16(11):946–950.
10. Glover SJ, Burgess PI, Cohen DB, Harding SP, Hofland HW, Zijlstra EE, Allain
TJ: Prevalence of diabetic retinopathy, cataract and visual impairment in
patients with diabetes in sub-Saharan Africa. Br J Ophthalmol 2012,
96(2):156–161.
Omar et al. BMC Ophthalmology 2014, 14:81 Page 7 of 7
http://www.biomedcentral.com/1471-2415/14/8111. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D,
Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy
Project Group: Proposed international clinical diabetic retinopathy and
diabetic macular edema disease severity scales. Ophthalmology 2003,
110(9):1677–1682.
12. Hall V, Thomsen RW, Henriksen O, Lohse N: Diabetes in Sub Saharan Africa
1999–2011: epidemiology and public health implications. A systematic
review. BMC Public Health 2011, 11:564.
13. Bloomgarden ZT: Screening for and managing diabetic retinopathy:
current approaches. Am J Health Syst Pharm 2007, 64(17 Suppl 12):S8–S14.
14. Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG, Unwin NC,
Essential Non-Communicable Disease Health Intervention P: Rural and
urban differences in diabetes prevalence in Tanzania: the role of obesity,
physical inactivity and urban living. Trans R Soc Trop Med Hyg 2000,
94(6):637–644.
15. Mo H: Cameroon Burden of Diabetes project (Cambod)
Cameroonbaseline survey report. 2004.
16. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM: Obesity in women
from developing countries. Eur J Clin Nutr 2000, 54(3):247–252.
17. Azevedo M, Alla S: Diabetes in sub-saharan Africa: kenya, mali,
mozambique, Nigeria, South Africa and zambia. Int J Diab Dev Ctries 2008,
28(4):101–108.
18. Tight blood pressure control and risk of macrovascular and
microvascular complications in type 2 diabetes: UKPDS 38. UK
Prospective Diabetes Study Group. BMJ 1998, 317(7160):703–713.
19. The effect of intensive diabetes treatment on the progression of diabetic
retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control
and Complications Trial. Arch Ophthalmol 1995, 113(1):36–51.
20. Intensive blood-glucose control with sulphonylureas or insulin compared
with conventional treatment and risk of complications in patients with
type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS)
Group. Lancet 1998, 352(9131):837–853.
21. Mbanya JC, Sobngwi E: Diabetes in Africa. Diabetes microvascular and
macrovascular disease in Africa. J Cardiovasc Risk 2003, 10(2):97–102.
22. Negahban K, Chern K: Cataracts associated with systemic disorders and
syndromes. Curr Opin Ophthalmol 2002, 13(6):419–422.
23. Ellis JD, Evans JM, Ruta DA, Baines PS, Leese G, MacDonald TM, Morris AD:
Glaucoma incidence in an unselected cohort of diabetic patients: is
diabetes mellitus a risk factor for glaucoma? DARTS/MEMO
collaboration. Diabetes Audit and Research in Tayside Study. Medicines
Monitoring Unit. Br J Ophthalmol 2000, 84(11):1218–1224.
24. Mitchell P, Smith W, Chey T, Healey PR: Open-angle glaucoma and
diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997,
104(4):712–718.
25. Gibbins RL, Owens DR, Allen JC, Eastman L: Practical application of the
European Field Guide in screening for diabetic retinopathy by using
ophthalmoscopy and 35 mm retinal slides. Diabetologia 1998, 41(1):59–64.
doi:10.1186/1471-2415-14-81
Cite this article as: Omar et al.: Evaluating the effectiveness of
opportunistic eye screening model for people with Diabetes
attending Diabetes clinic at Mnazi Mmoja hospital, Zanzibar. BMC
Ophthalmology 2014 14:81.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
